-
公开(公告)号:US20110306765A1
公开(公告)日:2011-12-15
申请号:US13202834
申请日:2010-02-23
申请人: Pamela A. Haile , Clark A. Sehon , Huan Wang
发明人: Pamela A. Haile , Clark A. Sehon , Huan Wang
IPC分类号: C07D471/10 , C07D401/06
CPC分类号: C07D471/10
摘要: The present invention relates to a method comprising reducing a ketone of formula I: with an enantioselective hydrogenating agent to form substantially enantiomerically pure alcohol of formula II: where R—R4 and m are as defined herein. The method of the present invention is useful for making CCR2 modulators as wells as precursors CCR2 modulators.
摘要翻译: 本发明涉及一种方法,其包括用对映选择性氢化剂还原式I的酮,以形成基本上为对映异构体的式II的醇:其中R-R4和m如本文所定义。 本发明的方法可用于制备CCR2调节剂作为前体CCR2调节剂。
-
公开(公告)号:US08563722B2
公开(公告)日:2013-10-22
申请号:US13202834
申请日:2010-02-23
申请人: Pamela A. Haile , Clark A. Sehon , Huan Wang
发明人: Pamela A. Haile , Clark A. Sehon , Huan Wang
IPC分类号: C07D471/10
CPC分类号: C07D471/10
摘要: The present invention relates to a method comprising reducing a ketone of formula I: with an enantioselective hydrogenating agent to form substantially enantiomerically pure alcohol of formula II: where R—R4 and m are as defined herein. The method of the present invention is useful for making CCR2 modulators as wells as precursors CCR2 modulators.
摘要翻译: 本发明涉及一种方法,其包括用对映选择性氢化剂还原式I的酮,以形成基本上为对映异构体的式II的醇:其中R-R4和m如本文所定义。 本发明的方法可用于制备CCR2调节剂作为前体CCR2调节剂。
-
公开(公告)号:US08431590B2
公开(公告)日:2013-04-30
申请号:US12665335
申请日:2008-06-20
申请人: Brian W. Budzik , Hilary Schenck Eidam , Ryan Michael Fox , Krista B. Goodman , Dimitar B. Gotchev , Pamela A. Haile , Terry Vincent Hughes , Ronggang Liu , Nathan A. Miller , Tamara Ann Miskowski , Clark A. Sehon , Andrew Q. Viet , Gren Z. Wang , Jing Zhang
发明人: Brian W. Budzik , Hilary Schenck Eidam , Ryan Michael Fox , Krista B. Goodman , Dimitar B. Gotchev , Pamela A. Haile , Terry Vincent Hughes , Ronggang Liu , Nathan A. Miller , Tamara Ann Miskowski , Clark A. Sehon , Andrew Q. Viet , Gren Z. Wang , Jing Zhang
IPC分类号: C07D401/04 , C07D401/14 , A61K31/438 , A61K31/4439
CPC分类号: C07D471/10
摘要: The present invention relates to a compound of the following formula: where R1-R6, R10, Y, n, m, p, and q are as defined herein. Compounds and compositions of the present invention are useful for the treatment of diseases associated with the overexpression of CCR2.
摘要翻译: 本发明涉及下式的化合物:其中R 1 -R 6,R 10,Y,n,m,p和q如本文所定义。 本发明的化合物和组合物可用于治疗与过度表达CCR2相关的疾病。
-
公开(公告)号:US20080318990A1
公开(公告)日:2008-12-25
申请号:US12142899
申请日:2008-06-20
IPC分类号: A61K31/438 , C07D471/10 , A61P25/28 , A61P3/10
CPC分类号: C07D471/10
摘要: The present invention relates to a compound of the following formula: where R1-R6, R10, Y, n, m, p, and q are as defined herein. Compounds and compositions of the present invention are useful for the treatment of diseases associated with the overexpression of CCR2.
摘要翻译: 本发明涉及下式的化合物:其中R 1 -R 6,R 10,Y,n,m,p和q如本文所定义。 本发明的化合物和组合物可用于治疗与过度表达CCR2相关的疾病。
-
公开(公告)号:US07723350B2
公开(公告)日:2010-05-25
申请号:US12142899
申请日:2008-06-20
IPC分类号: A61K31/438 , C07D471/10
CPC分类号: C07D471/10
摘要: The present invention relates to a compound of the following formula: where R1-R6, R10, Y, n, m, p, and q are as defined herein. Compounds and compositions of the present invention are useful for the treatment of diseases associated with the overexpression of CCR2.
摘要翻译: 本发明涉及下式的化合物:其中R 1 -R 6,R 10,Y,n,m,p和q如本文所定义。 本发明的化合物和组合物可用于治疗与过度表达CCR2相关的疾病。
-
公开(公告)号:US20130053375A1
公开(公告)日:2013-02-28
申请号:US13696603
申请日:2011-05-06
申请人: Michael Jonathan Bury , Linda N. Casillas , Adam Kenneth Charnley , Michael P. DeMartino , Xiaoyang Dong , Patrick Eidam , Pamela A. Haile , Philip Anthony Harris , Ami Lakdawala Shah , Bryan W. King , Robert W. Marquis, JR. , John F. Mehlmann , Joseph J. Romano , Clark A. Sehon
发明人: Michael Jonathan Bury , Linda N. Casillas , Adam Kenneth Charnley , Michael P. DeMartino , Xiaoyang Dong , Patrick Eidam , Pamela A. Haile , Philip Anthony Harris , Ami Lakdawala Shah , Bryan W. King , Robert W. Marquis, JR. , John F. Mehlmann , Joseph J. Romano , Clark A. Sehon
IPC分类号: A61K31/4706 , A61K31/4709 , C12N9/99 , C07D215/44 , C07D401/12 , C07D405/12 , C07D411/12 , C07D413/12 , C07D471/04 , C07D417/14 , C07D513/04 , C07D215/42 , A61K31/506 , C07D405/14 , C07D401/14 , C07D413/14 , A61K31/5377 , A61K31/541 , A61K31/496 , A61P29/00 , A61P11/06 , A61P17/00 , A61P1/00 , C07D417/12
CPC分类号: C07D215/42 , A61K31/47 , C07D215/44 , C07D215/48 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D411/12 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04 , C07D513/04
摘要: Disclosed are quinoline compounds having the formula: wherein R1, R2 and A are as defined herein, and methods of making and using the same.
摘要翻译: 公开了具有下式的喹啉化合物:其中R1,R2和A如本文所定义,以及制备和使用它们的方法。
-
公开(公告)号:US20130023532A1
公开(公告)日:2013-01-24
申请号:US13637419
申请日:2011-03-26
申请人: Linda N. Casillas , Subhas J. Chakravorty , Adam Kenneth Charnley , Pamela A. Haile , Terry Vincent Hughes , Jae U. Jeong , Jianxing Kang , Ami Lakdawala Shah , Lara Kathryn Leister , Robert W. Marquis, JR. , Nathan Andrew Miller , Daniel J. Price , Clark A. Sehon , Gren Z. Wang , Daohua Zhang , Patrick Eidam
发明人: Linda N. Casillas , Subhas J. Chakravorty , Adam Kenneth Charnley , Pamela A. Haile , Terry Vincent Hughes , Jae U. Jeong , Jianxing Kang , Ami Lakdawala Shah , Lara Kathryn Leister , Robert W. Marquis, JR. , Nathan Andrew Miller , Daniel J. Price , Clark A. Sehon , Gren Z. Wang , Daohua Zhang , Patrick Eidam
IPC分类号: A61K31/5377 , A61K31/437 , A61K31/454 , C07D409/14 , C07D471/04 , C07D401/12 , C07D405/14 , A61K31/506 , C07D403/12
CPC分类号: C07D403/12 , C07D409/14 , C07D471/04
摘要: Disclosed are compounds having the formula: or a salt thereof, wherein A, n, R1, R1A, and R2 are as defined herein, and methods of making and using the same.
摘要翻译: 公开了具有下式的化合物或其盐,其中A,n,R 1,R 1A和R 2如本文所定义,及其制备和使用方法。
-
公开(公告)号:US20130023534A1
公开(公告)日:2013-01-24
申请号:US13637430
申请日:2011-03-26
申请人: Linda N. Casillas , Subhas J. Chakravorty , Patrick Eidam , Pamela A. Haile , Terry Vincent Hughes , Ami Lakdawala Shah , Lara Kathryn Leister , Nathan Andrew Miller , Attiq Rahman , Clark A. Sehon , Gren Z. Wang , Daohua Zhang
发明人: Linda N. Casillas , Subhas J. Chakravorty , Patrick Eidam , Pamela A. Haile , Terry Vincent Hughes , Ami Lakdawala Shah , Lara Kathryn Leister , Nathan Andrew Miller , Attiq Rahman , Clark A. Sehon , Gren Z. Wang , Daohua Zhang
IPC分类号: A61K31/5377 , C07D413/14 , C07D401/14 , C07D409/14 , C07D417/14 , C07D401/12 , C07D413/12 , A61K31/506 , C07D405/14
CPC分类号: C07D403/12 , C07D401/14 , C07D405/14 , C07D409/14 , C07D413/14
摘要: Disclosed are compounds having the formula (I): wherein Z, n, R1, R1A, R3, R4, and R5 are as defined herein, and methods of making and using the same.
摘要翻译: 公开了具有式(I)的化合物:其中Z,n,R 1,R 1A,R 3,R 4和R 5如本文所定义,及其制备和使用方法。
-
公开(公告)号:US20110034499A1
公开(公告)日:2011-02-10
申请号:US12665335
申请日:2008-06-20
申请人: Brian W. Budzik , Hilary Schenck Eidam , Ryan Michael Fox , Krista B. Goodman , Dimitar B. Gotchev , Pamela A. Haile , Terry Vincent Hughes , Ronggang Liu , Nathan A. Miller , Tamara Ann Miskowski , Clark A. Sehon , Andrew Q. Viet , Gren Z. Wang , Jing Zhang
发明人: Brian W. Budzik , Hilary Schenck Eidam , Ryan Michael Fox , Krista B. Goodman , Dimitar B. Gotchev , Pamela A. Haile , Terry Vincent Hughes , Ronggang Liu , Nathan A. Miller , Tamara Ann Miskowski , Clark A. Sehon , Andrew Q. Viet , Gren Z. Wang , Jing Zhang
IPC分类号: A61K31/438 , C07D471/10 , A61P9/10 , A61P29/00 , A61P31/16 , A61P3/00 , A61P3/10 , A61P25/00 , A61P11/06 , A61P13/12 , A61P9/04 , A61P25/28 , A61P1/00 , A61P15/00
CPC分类号: C07D471/10
摘要: The present invention relates to a compound of the following formula: where R1-R6, R10, Y, n, m, p, and q are as defined herein. Compounds and compositions of the present invention are useful for the treatment of diseases associated with the overexpression of CCR2.
摘要翻译: 本发明涉及下式的化合物:其中R 1 -R 6,R 10,Y,n,m,p和q如本文所定义。 本发明的化合物和组合物可用于治疗与过度表达CCR2相关的疾病。
-
公开(公告)号:US20120041024A1
公开(公告)日:2012-02-16
申请号:US13206706
申请日:2011-08-10
IPC分类号: A61K31/4709 , A61P27/02 , A61P17/00 , A61P1/00 , A61P3/10 , A61P19/02 , A61P29/00 , A61P1/04 , C07D401/12 , A61P11/00
CPC分类号: C07D401/12 , C07D405/14
摘要: Disclosed are compounds having the formula: wherein R1, R2, R3, R4 and R5 are as defined herein, and methods of making and using the same.
摘要翻译: 公开了具有下式的化合物:其中R1,R2,R3,R4和R5如本文所定义,以及制备和使用它们的方法。
-
-
-
-
-
-
-
-
-